Fundz

Nxera Pharma Co., Ltd. Appoints Dr. Makoto Sugita as President of Nxera Pharma Japan and Executive Vice President and CMO

Oct 01, 2024

Position

Chief Medical Officer

Company

Nxera Pharma Ltd

Makoto Sugita
makoto@nxera.life
TokyoBiotechnologyPharmaceutical

Description

Nxera Pharma Co., Ltd. announces the appointment of Dr. Makoto Sugita, M.D., Ph.D., MBA, as President of Nxera Pharma Japan, and Executive Officer, Executive Vice President and Chief Medical Officer (CMO) of Nxera Pharma.

Who to call at Nxera Pharma Ltd, and when

A new leader at Nxera Pharma Ltd brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Nxera Pharma Ltd raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Nxera Pharma Ltd, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Nxera Pharma Ltd. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Nxera Pharma Ltd

Location

Tokyo, Tokyo, Japan

About

Nxera Pharma (formerly Sosei Heptares) is a technology powered biopharma company, in pursuit of new specialty medicines to improve the lives of patients with unmet needs in Japan and globally. In addition to several products being commercialized in Japan, we are advancing an extensive pipeline of over 30 active programs from discovery through to late clinical stage internally and in partnership with leading pharma and biotech companies. This pipeline is focused on addressing major unmet needs in some of the fastest-growing areas of medicine across neurology, GI and immunology, metabolic disorders and rare diseases, and leverages the power of our unique and industry leading GPCR-targeted structure-based drug discovery “NxWave” platform to provide a sustainable source of best- or first-in-class candidates.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Nxera Pharma Ltd changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Hironoshin
Likely contact at this company
••••••••@••••••••

See Hironoshin's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Nxera Pharma Ltd's next move

Learn about Strategic plan

Nxera Pharma Ltd changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.